Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.
(Q40100311)
scientific article
scientific article
Language:
Current Data About
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.